中国循证医学杂志

中国循证医学杂志

中医药临床疗效研究报告体系构建过程

查看全文

临床研究报告是临床证据的主要呈现形式。依据临床研究报告的要求,结合中医药临床研究的特点,构建中医药临床疗效研究报告规范体系,是一项重要的基础性系统工程。本文从中医药临床疗效研究报告中存在的问题、关注的重点、构建的过程等方面进行详细阐述,以期提高中医药临床疗效研究报告质量,为临床决策提供更优质的证据,促进中医药现代化发展。

Clinical research reports are the main form of clinical evidence. Based on the requirements of clinical research reports and the characteristics of clinical research on traditional Chinese medicine, it is an important basic systematic project to construct a standardized system of clinical curative effects study report on Chinese medicine. This article elaborates existing problems, focus of attention and construction process in order to help promote the improvement of clinical curative effects research report on Chinese medicine, provide more high-quality evidences for clinical decision-making and promote the development of Chinese medicine.

关键词: 报告规范; 中医药; 临床研究; 临床研究质量

Key words: Report specification; Chinese medicine; Clinical trial; Quality of clinical trial

引用本文: 田然, 赵晨, 郑颂华, 林伟青, 杨桢, 吴泰相, 杨克虎, 李幼平, 商洪才, 吕爱平, 卞兆祥. 中医药临床疗效研究报告体系构建过程. 中国循证医学杂志, 2018, 18(7): 651-653. doi: 10.7507/1672-2531.201801070 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
1. Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration. Ann Intern Med, 2017, 167(2): 112-121.
2. Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Traditional Chinese Version). Ann Intern Med, 2017, 167(2): W7-W20.
3. Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Simplified Chinese Version). Ann Intern Med, 2017, 167(2): W21-W34.
4. Macpherson H, Altman DG, Hammerschlag R. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med, 2010, 3(3): 35-46.
5. 尚志钧. 神农本草经校注. 北京: 学苑出版社, 2008.
6. Lewith GT, Aldridge D. Clinical research methodology for complementary therapies. London: Hodder and Stoughton, 1993.
7. 单平, 毛如宝, 徐济民, 等. 黄杨宁治疗冠心病-用双盲法观察 110 例临床疗效分析. 中医杂志, 1983, (5): 37-40.
8. Mcsp CS. Clinical Research Methodology for Complementary Therapies. Physiotherapy, 1993, 79(6):444.
9. Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg, 2011, 9(8): 672-677.
10. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg, 2010, 8(5): 336-341.
11. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev, 2015, 4(1): 1.
12. Stewart LA, Clarke M, Rovers M, et al. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD Statement. JAMA, 2015, 313(16): 1657-1665.
13. Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med, 2015, 162(11): 777-784.
14. Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med, 2013, 158(3): 200-207.
15. Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: consensus-based clinical case report guideline development. J Diet Suppl, 2013, 10(4): 381-390.
16. Fu SF, Cheng CW, Zhang L, et al. Consensus-based recommendations for case report in Chinese medicine (CARC). Chin J Integr Med, 2016, 22(1): 73-79.